Targeting cytokine and chemokine signaling pathways for cancer therapy

M Yi, T Li, M Niu, H Zhang, Y Wu, K Wu… - Signal Transduction and …, 2024 - nature.com
Cytokines are critical in regulating immune responses and cellular behavior, playing dual
roles in both normal physiology and the pathology of diseases such as cancer. These …

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

A Moinuddin, SM Poznanski, AL Portillo… - Immunological …, 2024 - Wiley Online Library
Natural Killer (NK) cells are a top contender in the development of adoptive cell therapies for
cancer due to their diverse antitumor functions and ability to restrict their activation against …

Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination

Z Zhou, Y Mai, G Zhang, Y Wang, P Sun, Z Jing, Z Li… - Cancer Letters, 2024 - Elsevier
Immunogenic cell death (ICD) is a stress-driven form of regulated cell death (RCD) in which
dying tumor cells' specific signaling pathways are activated to release damage-associated …

Parkin activates innate immunity and promotes anti-tumor immune responses

M Perego, M Yeon, E Agarwal, AT Milcarek… - The Journal of Clinical …, 2024 - jci.org
The activation of innate immunity and associated interferon (IFN) signaling have been
implicated in cancer, but the regulators are elusive and a link to tumor suppression …

Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy

H Zhou, W Wang, H Xu, Y Liang, J Ding, M Lv… - Nature …, 2024 - nature.com
Type I interferons have been well recognized for their roles in various types of immune cells
during tumor immunotherapy. However, their direct effects on tumor cells are less …

[PDF][PDF] Mechanisms of programmed cell death

T Li, G Kroemer - Immunological Reviews, 2023 - hal.science
The present volume of Immunological Reviews deals with the mechanisms of programmed
cell death, obviously from an immunological perspective. What are the consequences of cell …

Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis

Y Minayoshi, H Maeda, K Hamasaki, T Nagasaki… - Pharmaceuticals, 2024 - mdpi.com
Although a lot of effort has been put into creating drugs and combination therapies against
chronic hepatitis, no effective treatment has been established. Type-I interferon is a …

[HTML][HTML] Environment-responsive dendrobium polysaccharide hydrogel embedding manganese microsphere as a post-operative adjuvant to boost cascaded immune …

N Gao, Y Huang, S Jing, M Zhang, E Liu, L Qiu… - Theranostics, 2024 - ncbi.nlm.nih.gov
Rationale: Surgical resection is a primary treatment for solid tumors, but high rates of tumor
recurrence and metastasis post-surgery present significant challenges. Manganese (Mn 2+) …

TAGLN2 induces resistance signature ISGs by activating AKT-YBX1 signal with dual pathways and mediates the IFN-related DNA damage resistance in gastric cancer

H Zhuo, J Hou, Z Hong, S Yu, H Peng, L Zhang… - Cell Death & …, 2024 - nature.com
Recently, various cancer types have been identified to express a distinct subset of Interferon-
stimulated genes (ISGs) that mediate therapy resistance. The mechanism through which …

Immunological signatures from irradiated cancer-associated fibroblasts

R Berzaghi, K Gundersen, B Dille Pedersen… - Frontiers in …, 2024 - frontiersin.org
Introduction Cancer-associated fibroblasts (CAFs) are abundant and influential elements of
the tumor microenvironment (TME), giving support to tumor development in multiple ways …